Cancer Pain

Oncology·MeSH: Pain

12 drugs in development·10 companies·3 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
amitiza	SUCAMPO PHARMACEUTICALS, INC. (SCMP)
onsolis	BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)
onsolis/breakyl/painkyl	BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)
subsys	Insys Therapeutics, Inc. (INSY)
symproic	BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI)
Symproic	COLLEGIUM PHARMACEUTICAL, INC (COLL)

Phase 1(2)

Drug	Company
Paracetamol	PROTHENA CORP PUBLIC LTD CO (PRTA)
Paracetamol	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Preclinical(1)

Drug	Company
envelta	Virpax Pharmaceuticals, Inc. (VRPX)

N/A(2)

Drug	Company
Paracetamol	Cidara Therapeutics, Inc. (CDTX)
Paracetamol	Structure Therapeutics Inc. (GPCR)

Phase 4(1)

Drug	Company
Paracetamol	Filana Therapeutics Inc. (FLNA)

BioSniper tracks 12 drugs in development for Cancer Pain across 10 companies.

There are 3 clinical trials targeting Cancer Pain tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.